Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SI GROUP TO SHOWCASE SUSTAINABLE ADDITIVE INNOVATIONS AT K 2025 2025-09-15 20:30
Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc 2025-09-15 12:06
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations 2025-09-15 08:00
Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium 2025-09-15 07:45
The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration 2025-09-12 09:51
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine 2025-09-11 14:56
Fosun International Recognized among Fortune's 2025 "Most Admired Chinese Companies" List 2025-09-11 09:00
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis 2025-09-10 07:01
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals 2025-09-09 20:42
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder 2025-09-08 15:49
Gushengtang's H1 2025 Net Profit Climbs 41.6% Driven by Digital Health Adoption and International Expansion 2025-09-08 15:35
Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC 2025-09-05 21:38
FUTUONING Sets Sail Commercially with First Prescriptions Across China 2025-09-05 18:12
Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference 2025-09-04 20:00
US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively 2025-09-02 21:10
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants 2025-09-02 21:00
LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company 2025-09-02 08:00
Norma Completes Quantum AI Algorithm Validation on NVIDIA 2025-09-01 21:00
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress 2025-08-29 14:00
Everest Medicines Announces Interim Results for First Half of 2025 2025-08-29 07:52
1 8 9 10 11 12 280